BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 23619146)

  • 1. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis.
    Su L; Nalle SC; Shen L; Turner ES; Singh G; Breskin LA; Khramtsova EA; Khramtsova G; Tsai PY; Fu YX; Abraham C; Turner JR
    Gastroenterology; 2013 Aug; 145(2):407-15. PubMed ID: 23619146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction.
    Wang F; Schwarz BT; Graham WV; Wang Y; Su L; Clayburgh DR; Abraham C; Turner JR
    Gastroenterology; 2006 Oct; 131(4):1153-63. PubMed ID: 17030185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myosin light chain kinase expression induced via tumor necrosis factor receptor 2 signaling in the epithelial cells regulates the development of colitis-associated carcinogenesis.
    Suzuki M; Nagaishi T; Yamazaki M; Onizawa M; Watabe T; Sakamaki Y; Ichinose S; Totsuka M; Oshima S; Okamoto R; Shimonaka M; Yagita H; Nakamura T; Watanabe M
    PLoS One; 2014; 9(2):e88369. PubMed ID: 24520376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects and Mechanism of Constitutive TL1A Expression on Intestinal Mucosal Barrier in DSS-Induced Colitis.
    Yang M; Jia W; Wang D; Han F; Niu W; Zhang H; Shih DQ; Zhang X
    Dig Dis Sci; 2019 Jul; 64(7):1844-1856. PubMed ID: 30949903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis.
    Nighot P; Al-Sadi R; Rawat M; Guo S; Watterson DM; Ma T
    Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(12):G988-97. PubMed ID: 26514773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,25-Dihydroxyvitamin D Protects Intestinal Epithelial Barrier by Regulating the Myosin Light Chain Kinase Signaling Pathway.
    Du J; Chen Y; Shi Y; Liu T; Cao Y; Tang Y; Ge X; Nie H; Zheng C; Li YC
    Inflamm Bowel Dis; 2015 Nov; 21(11):2495-506. PubMed ID: 26287999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-mouse CD52 monoclonal antibody ameliorates intestinal epithelial barrier function in interleukin-10 knockout mice with spontaneous chronic colitis.
    Wang H; Dong J; Shi P; Liu J; Zuo L; Li Y; Gong J; Gu L; Zhao J; Zhang L; Zhang W; Zhu W; Li N; Li J
    Immunology; 2015 Feb; 144(2):254-62. PubMed ID: 25087772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myosin light chain kinase mediates intestinal barrier dysfunction via occludin endocytosis during anoxia/reoxygenation injury.
    Jin Y; Blikslager AT
    Am J Physiol Cell Physiol; 2016 Dec; 311(6):C996-C1004. PubMed ID: 27760753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis.
    Su L; Shen L; Clayburgh DR; Nalle SC; Sullivan EA; Meddings JB; Abraham C; Turner JR
    Gastroenterology; 2009 Feb; 136(2):551-63. PubMed ID: 19027740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial Nuclear Factor-x03BA;B Activation in Inflammatory Bowel Diseases and Colitis-Associated Carcinogenesis.
    Nagaishi T; Watabe T; Jose N; Tokai A; Fujii T; Matsuoka K; Nagahori M; Ohtsuka K; Watanabe M
    Digestion; 2016; 93(1):40-6. PubMed ID: 26789263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour necrosis factor--induced loss of intestinal barrier function requires TNFR1 and TNFR2 signalling in a mouse model of total parenteral nutrition.
    Feng Y; Teitelbaum DH
    J Physiol; 2013 Aug; 591(15):3709-23. PubMed ID: 23753529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wogonoside alleviates colitis by improving intestinal epithelial barrier function via the MLCK/pMLC2 pathway.
    Huang S; Fu Y; Xu B; Liu C; Wang Q; Luo S; Nong F; Wang X; Huang S; Chen J; Zhou L; Luo X
    Phytomedicine; 2020 Mar; 68():153179. PubMed ID: 32062328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total polysaccharides of the Sijunzi decoction attenuate tumor necrosis factor-α-induced damage to the barrier function of a Caco-2 cell monolayer
    Lu Y; Li L; Zhang JW; Zhong XQ; Wei JA; Han L
    World J Gastroenterol; 2018 Jul; 24(26):2867-2877. PubMed ID: 30018481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myosin light chain kinase mediates intestinal barrier disruption following burn injury.
    Chen C; Wang P; Su Q; Wang S; Wang F
    PLoS One; 2012; 7(4):e34946. PubMed ID: 22529961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of IFN-γ and TNF-α-induced intestinal epithelial barrier dysfunction by berberine via suppression of MLCK-MLC phosphorylation signaling pathway.
    Cao M; Wang P; Sun C; He W; Wang F
    PLoS One; 2013; 8(5):e61944. PubMed ID: 23671580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chang'an II Decoction ( II )-Containing Serum Ameliorates Tumor Necrosis Factor-α-Induced Intestinal Epithelial Barrier Dysfunction via MLCK-MLC Signaling Pathway in Rats.
    Chen T; Yin XL; Kang N; Wang XG; Li BS; Ji HJ; Zhang YQ; Bian LQ; Zhang BH; Wang FY; Tang XD
    Chin J Integr Med; 2020 Oct; 26(10):745-753. PubMed ID: 31768870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LIGHT signals directly to intestinal epithelia to cause barrier dysfunction via cytoskeletal and endocytic mechanisms.
    Schwarz BT; Wang F; Shen L; Clayburgh DR; Su L; Wang Y; Fu YX; Turner JR
    Gastroenterology; 2007 Jun; 132(7):2383-94. PubMed ID: 17570213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aryl Hydrocarbon Receptor Activation Modulates Intestinal Epithelial Barrier Function by Maintaining Tight Junction Integrity.
    Yu M; Wang Q; Ma Y; Li L; Yu K; Zhang Z; Chen G; Li X; Xiao W; Xu P; Yang H
    Int J Biol Sci; 2018; 14(1):69-77. PubMed ID: 29483826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity.
    Weber CR; Raleigh DR; Su L; Shen L; Sullivan EA; Wang Y; Turner JR
    J Biol Chem; 2010 Apr; 285(16):12037-46. PubMed ID: 20177070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis.
    Conlin VS; Wu X; Nguyen C; Dai C; Vallance BA; Buchan AM; Boyer L; Jacobson K
    Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G735-50. PubMed ID: 19661153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.